Envoy Medical (COCH) Competitors $1.64 -0.08 (-4.36%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COCH vs. AVR, PDEX, KRMD, LUNG, LUCD, INFU, ZJYL, OBIO, ICAD, and GUTSShould you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Anteris Technologies Global (AVR), Pro-Dex (PDEX), KORU Medical Systems (KRMD), Pulmonx (LUNG), Lucid Diagnostics (LUCD), InfuSystem (INFU), Jin Medical International (ZJYL), Orchestra BioMed (OBIO), iCAD (ICAD), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. Envoy Medical vs. Anteris Technologies Global Pro-Dex KORU Medical Systems Pulmonx Lucid Diagnostics InfuSystem Jin Medical International Orchestra BioMed iCAD Fractyl Health Anteris Technologies Global (NASDAQ:AVR) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk. Is AVR or COCH more profitable? Anteris Technologies Global has a net margin of 0.00% compared to Envoy Medical's net margin of -7,607.55%. Company Net Margins Return on Equity Return on Assets Anteris Technologies GlobalN/A N/A N/A Envoy Medical -7,607.55%N/A -262.28% Which has higher earnings & valuation, AVR or COCH? Anteris Technologies Global has higher revenue and earnings than Envoy Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnteris Technologies Global$2.71M47.89N/AN/AN/AEnvoy Medical$212K165.49-$29.91M-$1.38-1.19 Do analysts rate AVR or COCH? Anteris Technologies Global presently has a consensus price target of $16.50, suggesting a potential upside of 358.33%. Envoy Medical has a consensus price target of $9.13, suggesting a potential upside of 454.71%. Given Envoy Medical's higher probable upside, analysts plainly believe Envoy Medical is more favorable than Anteris Technologies Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in AVR or COCH? 8.6% of Envoy Medical shares are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer AVR or COCH? Envoy Medical received 4 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. CompanyUnderperformOutperformAnteris Technologies GlobalOutperform Votes4100.00% Underperform VotesNo VotesEnvoy MedicalOutperform Votes8100.00% Underperform VotesNo Votes Does the media favor AVR or COCH? In the previous week, Anteris Technologies Global had 1 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for Anteris Technologies Global and 2 mentions for Envoy Medical. Anteris Technologies Global's average media sentiment score of 0.93 beat Envoy Medical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAnteris Technologies Global beats Envoy Medical on 6 of the 11 factors compared between the two stocks. Get Envoy Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COCH vs. The Competition Export to ExcelMetricEnvoy MedicalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.98M$9.51B$5.36B$8.40BDividend YieldN/A1.61%5.22%4.11%P/E Ratio-1.1920.9526.6219.74Price / Sales165.4965.25391.30117.36Price / CashN/A19.6738.2534.62Price / Book-18.285.066.804.51Net Income-$29.91M$284.66M$3.23B$248.18M7 Day Performance-3.24%-0.82%4.02%1.07%1 Month Performance25.57%4.88%12.19%14.96%1 Year Performance-46.07%-20.93%17.04%6.70% Envoy Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COCHEnvoy Medical1.7668 of 5 stars$1.65-4.4%$9.13+454.7%-46.9%$34.98M$212,000.00-1.1934AVRAnteris Technologies GlobalN/A$3.99-3.9%$16.50+313.5%N/A$143.89M$2.71M0.00138Gap DownPDEXPro-Dex2.6471 of 5 stars$43.23+0.3%$52.00+20.3%+130.9%$140.97M$64.12M21.51140News CoveragePositive NewsKRMDKORU Medical Systems2.6581 of 5 stars$2.97+0.7%$4.50+51.5%+34.1%$137.04M$35.08M-11.8880Gap DownLUNGPulmonx3.5245 of 5 stars$3.34-2.6%$12.07+261.4%-62.4%$134.46M$87.47M-2.32250Positive NewsLUCDLucid Diagnostics3.0297 of 5 stars$1.26flat$3.50+177.8%+39.8%$132.78M$4.35M-1.1170INFUInfuSystem2.4909 of 5 stars$6.12-0.5%$13.00+112.4%N/A$128.62M$137.58M102.02410News CoverageHigh Trading VolumeZJYLJin Medical InternationalN/A$0.81+1.2%N/A-74.2%$126.24M$23.50M0.00245OBIOOrchestra BioMed2.8577 of 5 stars$2.92+0.7%$14.20+386.3%-43.6%$111.11M$2.89M-1.814Gap UpICADiCAD0.4759 of 5 stars$3.98-0.3%N/A+141.5%$109.24M$19.61M-30.62140News CoverageAnalyst ForecastGap UpGUTSFractyl Health1.7382 of 5 stars$2.12+25.4%$11.00+418.9%-69.9%$103.83M$93,000.00-0.17102High Trading Volume Related Companies and Tools Related Companies Anteris Technologies Global Competitors Pro-Dex Competitors KORU Medical Systems Competitors Pulmonx Competitors Lucid Diagnostics Competitors InfuSystem Competitors Jin Medical International Competitors Orchestra BioMed Competitors iCAD Competitors Fractyl Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COCH) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COCH Stock Free COCH Stock Alerts